Exhibit 107
CALCULATION OF FILING FEES TABLE
FORM S-3
(Form Type)
Allarity Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security Type | Security Class Title | Fee Calculation Rule | Amount Registered(1) | Proposed Maximum Offering Price Per Share(2) | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | |||||||||||||||||
| Equity | Common Stock, par value $0.0001 per share | Other | 18,529,000 | $ | 0.165 | $ | 3,057,285 | 0.00014760 | $ | 451 | ||||||||||||||
| Total Offering Amounts | $ | 3,057,285 | $ | 451 | ||||||||||||||||||||
| Total Fee Offsets | — | — | ||||||||||||||||||||||
| Net Fee Due | $ | 451 | ||||||||||||||||||||||
| (1) | This registration statement, to which this exhibit is attached, (the “Registration Statement”) registers 18,529,000 shares of common stock, par value $0.0001 per share (“Common Stock”) that will become issuable upon conversion of the Selling Stockholders’ 35,000 shares of our Series A Convertible Redeemable Preferred Stock, par value $0.0001 per share (“Preferred Stock”) of Allarity Therapeutics, Inc. to be offered for resale by the Selling Stockholders. Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), the Registration Statement shall also cover any additional shares of Common Stock as may be issuable upon stock splits, stock dividends, or other distribution, recapitalization or similar events. |
| (2) | Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) promulgated under the Securities Act. The proposed maximum offering price per share is based on the average of the high and the low prices of Common Stock, as reported on the Nasdaq Capital Market on August 27, 2024. |
